Prof.Dr.Med. ID: 42745

Guido Sauter

graph of relations

Publications

  1. 2013
  2. Marked heterogeneity of ERG expression in large primary prostate cancers.

    Minner, S., Gärtner, M., Freudenthaler, F., Bauer, M., Kluth, M., Salomon, G., Heinzer, H., Graefen, M., Bokemeyer, C., Simon, R., Sauter, G., Schlomm, T. & Wilczak, W., 2013, In: MODERN PATHOL. 26, 1, p. 106-116 11 p., 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer.

    Burandt, E. C., Jens, G., Holst, F., Jänicke, F., Müller, V., Quaas, A., Choschzick, M., Wilczak, W., Terracciano, L., Simon, R., Sauter, G. & Lebeau, A., 2013, In: BREAST CANCER RES TR. 137, 3, p. 745-753 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  4. Prognostic relevance of ubiquitin C-terminal hydrolase L1 (UCH-L1) mRNA and protein expression in breast cancer patients

    Schröder, C., Milde-Langosch, K., Gebauer, F., Schmid, K., Müller, V., Wirtz, R. M., Meyer-Schwesinger, C., Schluter, H., Sauter, G. & Schumacher, U., 2013, In: J CANCER RES CLIN. 139, p. 1745-1755 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. Prognostic value of alpha-methyl CoA racemase (AMACR) expression in renal cell carcinoma.

    Eichelberg, C., Minner, S., Isbarn, H., Burandt, E., Terracciano, L., Moch, H., Kell, A., Heuer, R., Chun, F. K., Sauter, G., Fisch, M. & Tennstedt, P., 2013, In: WORLD J UROL. 31, 4, p. 847-53 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. Strong expression of the neuronal transcription factor FOXP2 is linked to an increased risk of early PSA recurrence in ERG fusion-negative cancers.

    Stumm, L., Burkhardt, L., Steurer, S., Simon, R., Adam, M., Becker, A., Sauter, G., Minner, S., Schlomm, T., Sirma, H. & Michl, U., 2013, In: J CLIN PATHOL. 66, 7, p. 563-568 6 p., 7.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  7. 2012
  8. Intratumoral T but not B lymphocytes are related to clinical outcome in prostate cancer

    Flammiger, A., Bayer, F., Cirugeda-Kühnert, A., Huland, H., Tennstedt, P., Simon, R., Minner, S., Bokemeyer, C., Sauter, G., Schlomm, T. & Trepel, M., 11.2012, In: APMIS. 120, 11, p. 901-8 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  9. Epidermal growth factor receptor (EGFR) in salivary gland carcinomas: potentials as therapeutic target.

    Clauditz, T., Gontarewicz, A., Lebok, P., Tsourlakis, M. C., Grob, T., Münscher, A., Sauter, G., Bokemeyer, C., Knecht, R. & Wilczak, W., 01.10.2012, In: ORAL ONCOL. 48, 10, p. 991-996 6 p., 10.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  10. Staging and outcome depending on surgical treatment in adenocarcinomas of the oesophagogastric junction

    Reeh, M., Mina, S., Bockhorn, M., Kutup, A., Nentwich, M. F., Marx, A., Sauter, G., Rösch, T., Izbicki, J. R. & Bogoevski, D., 01.10.2012, In: BRIT J SURG. 99, 10, p. 1406-14 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  11. High level of Ets-related gene expression has high specificity for prostate cancer: a tissue microarray study of 11 483 cancers.

    Minner, S. J. P., Lübke, A., Kluth, M., Bokemeyer, C., Jänicke, F., Izbicki, J. R., Schlomm, T., Sauter, G. & Wilczak, W., 01.09.2012, In: HISTOPATHOLOGY. 61, 3, p. 445-453 9 p., 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  12. Reduced CD151 expression is related to advanced tumour stage in urothelial bladder cancer

    Minner, S. J. P., De Silva, C., Rink, M., Dahlem, R., Chun, F., Fisch, M., Höppner, W., Wagner, W., Bokemeyer, C., Terracciano, L., Simon, R., Sauter, G. & Wilczak, W., 08.2012, In: PATHOLOGY. 44, 5, p. 448-452 5 p., 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  13. ALCAM (CD166) expression and serum levels are markers for poor survival of esophageal cancer patients

    Tachezy, M., Harms-Effenberger, K., Zander, H., Minner, S. J. P., Gebauer, F., Vashist, Y., Sauter, G., Pantel, K., Izbicki, J. R. & Bockhorn, M., 15.07.2012, In: INT J CANCER. 131, 2, p. 396-405 10 p., 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  14. Adhesion molecule L1 is down-regulated in malignant peripheral nerve sheath tumors versus benign neurofibromatosis type 1-associated tumors

    Blessmann, M., Gröbe, A., Quaas, A., Kaifi, J. T., Mistakidis, G., Bernreuther, C., Sauter, G., Gros, S., Rawnaq, T., Friedrich, R., Mautner, V. F., Smeets, R., Heiland, M., Schachner, M. & Izbicki, J. R., 01.02.2012, In: OR SURG OR MED OR PA. 113, 2, p. 239-44 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  15. Virtual autopsy as an alternative to traditional medical autopsy in the intensive care unit: a prospective cohort study.

    Wichmann, D., Obbelode, F., Vogel, H., Hoepker, W. W., Nierhaus, A., Braune, S., Sauter, G., Püschel, K. & Kluge, S., 17.01.2012, In: ANN INTERN MED. 156, 2, p. 123-130 8 p., 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  16. 11q21 rearrangement is a frequent and highly specific genetic alteration in mucoepidermoid carcinoma

    Clauditz, T., Gontarewicz, A., Wang, C-J., Münscher, A., Laban, S., Tsourlakis, M. C., Knecht, R., Sauter, G. & Wilczak, W., 2012, In: DIAGN MOL PATHOL. 21, 3, p. 134-137 4 p., 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. BIRC2 amplification in squamous cell carcinomas of the uterine cervix.

    Choschzick, M., Tabibzada, A. M., Gieseking, F., Wölber, L., Jänicke, F., Sauter, G. & Simon, R., 2012, In: VIRCHOWS ARCH. 461, 2, p. 123-128 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  18. Clinical relevance of loss of 11p15 in primary and metastatic breast cancer: association with loss of PRKCDBP expression in brain metastases.

    Wikman, H., Sielaff-Frimpong, B., Kropidlowski, J., Witzel, I., Milde-Langosch, K., Sauter, G., Westphal, M., Lamszus, K. & Pantel, K., 2012, In: PLOS ONE. 7, 10, p. 47537 10.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  19. Genome-wide DNA methylation events in TMPRSS2-ERG fusion-negative prostate cancers implicate an EZH2-dependent mechanism with miR-26a hypermethylation.

    Börno, S. T., Fischer, A., Kerick, M., Fälth, M., Laible, M., Brase, J. C., Kuner, R., Dahl, A., Grimm, C., Sayanjali, B., Isau, M., Röhr, C., Wunderlich, A., Timmermann, B., Claus, R., Plass, C., Graefen, M., Simon, R., Demichelis, F., Rubin, M. A., Sauter, G., Schlomm, T., Sültmann, H., Lehrach, H. & Schweiger, M. R., 2012, In: CANCER DISCOV. 2, 11, p. 1024-1035 11.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  20. Genomic deletion of PTEN is associated with tumor progression and early PSA recurrence in ERG fusion-positive and fusion-negative prostate cancer.

    Krohn, A., Diedler, T., Burkhardt, L., Mayer, P. S., Colin, D. S., Meyer-Kornblum, M., Kötschau, D., Tennstedt, P., Huang, J., Gerhäuser, C., Mader, M., Kurtz, S., Sirma, H., Saad, F., Steuber, T., Graefen, M., Plass, C., Sauter, G., Simon, R., Minner, S. J. P. & Schlomm, T., 2012, In: AM J PATHOL. 181, 2, p. 401-412 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  21. Human prostate cancer in a clinically relevant xenograft mouse model: identification of β(1,6)-branched oligosaccharides as a marker of tumor progression.

    Lange, T., Ullrich, S., Müller, I., Nentwich, M., Stübke, K., Feldhaus, S., Knies, C., Hellwinkel, O., Vessella, R. L., Abramjuk, C., Anders, M., Schröder-Schwarz, J., Schlomm, T., Huland, H., Sauter, G. & Schumacher, U., 2012, In: CLIN CANCER RES. 18, 5, p. 1364-1373 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  22. Immunoexpression analysis and prognostic value of BLCAP in breast cancer.

    Gromova, I., Gromov, P., Kroman, N., Wielenga, V. T., Simon, R., Sauter, G. & Moreira, J. M. A., 2012, In: PLOS ONE. 7, 9, p. 45967 9.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  23. L1 is highly expressed in tumors of the nervous system: a study of over 8000 human tissues.

    Rawnaq, T., Quaas, A., Zander, H., Gros, S., Reichelt, U., Blessmann, M., Wilczak, W., Schachner, M., Sauter, G., Izbicki, J. R. & Kaifi, J., 2012, In: J SURG RES. 173, 2, p. 314-319 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  24. Moderne Leichenschau

    Heinemann, A., Seifert, D., Denzer, U. W., Rösch, T., Lorenzen, M., Adam, G., Wichmann, D., Kluge, S., Vogel, H., Sauter, G. & Püschel, K., 2012, In: Hamb Ärztebl. 66, 06/07, p. 12-17 06/07.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  25. Neurovascular structure-adjacent frozen-section examination (NeuroSAFE) increases nerve-sparing frequency and reduces positive surgical margins in open and robot-assisted laparoscopic radical prostatectomy: experience after 11,069 consecutive patients.

    Schlomm, T., Tennstedt, P., Huxhold, C., Steuber, T., Salomon, G., Michl, U., Heinzer, H., Hansen, J., Budäus, L., Steurer, S., Wittmer, C., Minner, S. J. P., Haese, A., Sauter, G., Graefen, M. & Huland, H., 2012, In: EUR UROL. 62, 2, p. 333-340 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  26. Opposite roles of FOXA1 and NKX2-1 in lung cancer progression.

    Deutsch, L., Wrage, M., Koops, S., Glatzel, M., Uzunoglu, F. G., Kutup, A., Hinsch, A., Sauter, G., Izbicki, J. R., Pantel, K. & Wikman, H., 2012, In: GENE CHROMOSOME CANC. 51, 6, p. 618-629 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  27. Peroxiredoxins 3 and 4 are overexpressed in prostate cancer tissue and affect the proliferation of prostate cancer cells in vitro.

    Ummanni, R., Barreto, F., Venz, S., Scharf, C., Barett, C., Mannsperger, H. A., Brase, J. C., Kuner, R., Schlomm, T., Sauter, G., Sültmann, H., Korf, U., Bokemeyer, C., Walther, R., Brümmendorf, T. & Balabanov, S., 2012, In: J PROTEOME RES. 11, 4, p. 2452-2466 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  28. PTEN deletion is rare but often homogeneous in gastric cancer.

    Mina, S., Bohn, B., Simon, R., Krohn, A., Reeh, M., Arnold, D., Bokemeyer, C., Sauter, G., Izbicki, J. R., Marx, A. & Stahl, P., 2012, In: J CLIN PATHOL. 65, 8, p. 693-698 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  29. Rare oncogenic mutations of predictive markers for targeted therapy in triple-negative breast cancer.

    Grob, T., Heilenkötter, U., Geist, S., Paluchowski, P., Wilke, C., Jänicke, F., Quaas, A., Wilczak, W., Choschzick, M., Sauter, G. & Lebeau, A., 2012, In: BREAST CANCER RES TR. 134, 2, p. 561-567 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  30. Relevance of PTEN loss in brain metastasis formation in breast cancer patients.

    Wikman, H., Lamszus, K., Detels, N., Uslar, L., Wrage, M., Benner, C., Hohensee, I., Ylstra, B., Eylmann, K., Zapatka, M., Sauter, G., Kemming, D., Glatzel, M., Müller, V., Westphal, M. & Pantel, K., 2012, In: BREAST CANCER RES. 14, 2, p. 49 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  31. Role of cyclin D1 amplification and expression in vulvar carcinomas.

    Choschzick, M., Hess, S., Tennstedt, P., Holst, F., Bohlken, H., Gieseking, F., Mahner, S., Wölber, L., Simon, R. & Sauter, G., 2012, In: HUM PATHOL. 43, 9, p. 1386-1393 9.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  32. Role of KCNMA1 in breast cancer.

    Oeggerli, M., Tian, Y., Ruiz, C., Wijker, B., Sauter, G., Obermann, E., Güth, U., Zlobec, I., Sausbier, M., Kunzelmann, K. & Bubendorf, L., 2012, In: PLOS ONE. 7, 8, p. 41664 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  33. Sef downregulation by Ras causes MEK1/2 to become aberrantly nuclear localized leading to polyploidy and neoplastic transformation.

    Duhamel, S., Hébert, J., Gaboury, L., Bouchard, A., Simon, R., Sauter, G., Basik, M. & Meloche, S., 2012, In: CANCER RES. 72, 3, p. 626-635 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  34. Y chromosome losses are exceedingly rare in prostate cancer and unrelated to patient age.

    Stahl, P., Kilgué, A., Tennstedt, P., Minner, S. J. P., Krohn, A., Simon, R., Krause, G., Izbicki, J. R., Graefen, M., Sauter, G., Schlomm, T. & Wilczak, W., 2012, In: PROSTATE. 72, 8, p. 898-903 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  35. 2011
  36. ALCAM (CD166) expression as novel prognostic biomarker for pancreatic neuroendocrine tumor patients.

    Tachezy, M., Zander, H., Marx, A. H., Gebauer, F., Rawnaq, T., Kaifi, J. T., Sauter, G., Izbicki, J. R. & Bockhorn, M., 01.10.2011, In: J SURG RES. 170, 2, p. 226-232 7 p., 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  37. Expression of TGF-β receptor ALK-5 has a negative impact on outcome of patients with acute myeloid leukemia

    Otten, J., Schmitz, L., Vettorazzi, E., Schultze, A., Marx, A. H., Simon, R., Krauter, J., Loges, S., Sauter, G., Bokemeyer, C. & Fiedler, W., 01.02.2011, In: LEUKEMIA. 25, 2, p. 375-9 5 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  38. Miliary never-smoking adenocarcinoma of the lung: strong association with epidermal growth factor receptor exon 19 deletion.

    Laack, E., Simon, R., Regier, M., Andritzky, B., Tennstedt, P., Habermann, C., Verth, C. Z., Thoem, I., Grob, T., Sauter, G. & Bokemeyer, C., 01.01.2011, In: J THORAC ONCOL. 6, 1, p. 199-202 4 p., 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  39. Adjuvant trastuzumab in HER2-positive breast cancer.

    Slamon, D., Eiermann, W., Robert, N., Pienkowski, T., Martin, M., Press, M., Mackey, J., Glaspy, J., Chan, A., Pawlicki, M., Pinter, T., Valero, V., Liu, M-C., Sauter, G., von Minckwitz, G., Visco, F., Bee, V., Buyse, M., Bendahmane, B., Tabah-Fisch, I., Lindsay, M-A., Riva, A., Crown, J. & Group, B. C. I. R., 2011, In: NEW ENGL J MED. 365, 14, p. 1273-1283 14.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  40. Alteration of topoisomerase II-alpha gene in human breast cancer: association with responsiveness to anthracycline-based chemotherapy.

    Press, M. F., Sauter, G., Buyse, M., Bernstein, L., Guzman, R., Santiago, A., Villalobos, I. E., Eiermann, W., Pienkowski, T., Martin, M., Robert, N., Crown, J., Bee, V., Taupin, H., Flom, K. J., Tabah-Fisch, I., Pauletti, G., Lindsay, M-A., Riva, A. & Slamon, D. J., 2011, In: J CLIN ONCOL. 29, 7, p. 859-867 7.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  41. Control of bone formation by the serpentine receptor Frizzled-9.

    Albers, J., Schulze, J., Beil, F. T., Gebauer, M., Baranowsky, A., Keller, J., Marshall, R-P., Wintges, K., Friedrich, F., Priemel, M., Schilling, A., Rueger, J. M., Cornils, K., Fehse, B., Streichert, T., Sauter, G., Jakob, F., Insogna, K. L., Pober, B., Knobeloch, K-P., Francke, U., Amling, M. & Schinke, T., 2011, In: J CELL BIOL. 192, 6, p. 1057-1072 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  42. ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapy.

    Minner, S. J. P., Enodien, M., Sirma, H., Lübke, A., Krohn, A., Mayer, P. S., Simon, R., Tennstedt, P., Müller, J., Scholz, L., Brase, J. C., Liu, A. Y., Schlüter, H., Pantel, K., Schumacher, U., Bokemeyer, C., Steuber, T., Graefen, M., Sauter, G. & Schlomm, T., 2011, In: CLIN CANCER RES. 17, 18, p. 5878-5888 18.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  43. High CD10 expression in lymph node metastases from surgically treated prostate cancer independently predicts early death.

    Fleischmann, A., Rocha, C., Saxer-Sekulic, N., Zlobec, I., Sauter, G. & Thalmann, G. N., 2011, In: VIRCHOWS ARCH. 458, 6, p. 741-748 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  44. High-level cytoplasmic cyclin D1 expression in lymph node metastases from prostate cancer independently predicts early biochemical failure and death in surgically treated patients.

    Fleischmann, A., Rocha, C., Saxer-Sekulic, N., Zlobec, I., Sauter, G. & Thalmann, G. N., 2011, In: HISTOPATHOLOGY. 58, 5, p. 781-789 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  45. High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer.

    Minner, S. J. P., Wittmer, C., Graefen, M., Salomon, G., Steuber, T., Haese, A., Huland, H., Bokemeyer, C., Yekebas, E. F., Dierlamm, J., Balabanov, S., Kilic, E., Wilczak, W., Simon, R., Sauter, G. & Schlomm, T., 2011, In: PROSTATE. 71, 3, p. 281-288 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  46. How radical should surgery be for early esophageal cancer?

    Bogoevski, D., Bockhorn, M., König, A., Reeh, M., von Loga, K., Sauter, G., Rösch, T. & Izbicki, J. R., 2011, In: WORLD J SURG. 35, 6, p. 1311-1320 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  47. Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas.

    Clauditz, T., Reiff, M., Gravert, L., Gnoss, A., Tsourlakis, M. C., Münscher, A., Sauter, G., Bokemeyer, C., Knecht, R. & Wilczak, W., 2011, In: PATHOLOGY. 43, 5, p. 459-464 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  48. Identification of Clinically Relevant Protein Targets in Prostate Cancer with 2D-DIGE Coupled Mass Spectrometry and Systems Biology Network Platform.

    Ummanni, R., Mundt, F., Pospisil, H., Venz, S., Scharf, C., Barett, C., Fälth, M., Köllermann, J., Walther, R., Schlomm, T., Sauter, G., Bokemeyer, C., Sültmann, H., Schuppert, A., Brümmendorf, T. & Balabanov, S., 2011, In: PLOS ONE. 6, 2, p. 16833 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  49. Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure.

    Peck, A. R., Witkiewicz, A. K., Liu, C., Stringer, G. A., Klimowicz, A. C., Pequignot, E., Freydin, B., Tran, T. H., Yang, N., Rosenberg, A. L., Hooke, J. A., Kovatich, A. J., Nevalainen, M. T., Shriver, C. D., Hyslop, T., Sauter, G., Rimm, D. L., Magliocco, A. M. & Rui, H., 2011, In: J CLIN ONCOL. 29, 18, p. 2448-2458 18.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  50. Low activated leukocyte cell adhesion molecule expression is associated with advanced tumor stage and early prostate-specific antigen relapse in prostate cancer.

    Minner, S. J. P., Kraetzig, F., Tachezy, M., Kilic, E., Graefen, M., Wilczak, W., Bokemeyer, C., Huland, H., Sauter, G. & Schlomm, T., 2011, In: HUM PATHOL. 42, 12, p. 1946-1952 12.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  51. MMSET is highly expressed and associated with aggressiveness in neuroblastoma.

    Hudlebusch, H. R., Skotte, J., Santoni-Rugiu, E., Zimling, Z. G., Lees, M. J., Simon, R., Sauter, G., Rota, R., Ioris, D., Antonietta, M., Quarto, M., Johansen, J. V., Jørgensen, M., Rechnitzer, C., Maroun, L. L., Schrøder, H., Petersen, B. L. & Helin, K., 2011, In: CANCER RES. 71, 12, p. 4226-4235 12.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  52. [Molecular diagnosis and therapy in oncology].

    Baretton, G., Grabbe, S., Keilholz, U. & Sauter, G., 2011, In: ONKOLOGIE. 34 Suppl 2, p. 5-9

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  53. Multicenter phase III randomized trial comparing docetaxel and trastuzumab with docetaxel, carboplatin, and trastuzumab as first-line chemotherapy for patients with HER2-gene-amplified metastatic breast cancer (BCIRG 007 study): two highly active therapeutic regimens.

    Valero, V., Forbes, J., Pegram, M. D., Pienkowski, T., Eiermann, W., von Minckwitz, G., Roche, H., Martin, M., Crown, J., Mackey, J. R., Fumoleau, P., Rolski, J., Mrsic-Krmpotic, Z., Jagiello-Gruszfeld, A., Riva, A., Buyse, M., Taupin, H., Sauter, G., Press, M. F. & Slamon, D. J., 2011, In: J CLIN ONCOL. 29, 2, p. 149-156 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review